Not finding it? Sign in to also search OpenAlex live.
-
Obicetrapib Alone and in Combination with Ezetimibe Reduces Non-HDL-Cholesterol by Enhanced LDL-Receptor-Mediated VLDL Clearance and Increased Net Fecal Sterol Excretion in ApoE*3-Leiden.CETP Mice
José A. Inia, Nanda Keijzer, Nicole Worms, Anita van Nieuwkoop, Marc Ditmarsch, J. Wouter Jukema, +3 more
0citations -
Obicetrapib alone and in combination with ezetimibe reduces non-HDL-cholesterol by enhanced LDL-receptor-mediated VLDL clearance and increased net fecal sterol excretion in apoe*3-leiden.cetp mice
José A. Inia, Nanda Keijzer, Nicole Worms, Anita van Nieuwkoop, Marc Ditmarsch, J. Wouter Jukema, +5 more
1citations -
L ow‐density lipoprotein cholesterol and non‐high‐density lipoprotein cholesterol in type 1 diabetes and type 2 diabetes: Lipid goal attainment in a large German–Austrian diabetes registry2023 Diabetes Obesity and Metabolism article Medicine Lipoproteins and Cardiovascular Health Open access
Julia Brandts, Sascha René Tittel, Peter Bramlage, Thomas Danne, Johanna Maria Brix, Stefan Zimny, +3 more
30citations -
Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab2020 European Journal of Preventive Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Antonio J. Vallejo‐Vaz, Lawrence A. Leiter, Stefano Del Prato, Marja‐Riitta Taskinen, Dirk Müller‐Wieland, Maja Bujas‐Bobanovic, +4 more
15citations -
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism2021 European Heart Journal article Medicine Cholesterol and Lipid Metabolism Open access cited by 4 patents
Arash Haghikia, Friederike Zimmermann, Andrzej Jasina, Johann Roessler, Philipp Heinze, Johannes Kaisler, +24 more
372citations -
Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis2021 Cardiovascular Research article Biochemistry, Genetics and Molecular Biology Fibroblast Growth Factor Research Open access cited by 2 patents
Cong Liu, Milena Schönke, Enchen Zhou, Zhuang Li, Sander Kooijman, Mariëtte R. Boon, +7 more
85citations -
The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project
Ulrich Laufs, Alberico Luigi Catapano, Raffaele De Caterina, François Schiele, Alessandro Sionís, Azfar Zaman, +1 more
33citations -
Time‐dependent lipid profile inversely associates with mortality in hemodialysis patients – independent of inflammation/malnutrition2021 Journal of Internal Medicine article Medicine Dialysis and Renal Disease Management Open access
Thomas Ebert, Abdul Rashid Qureshi, Claudia Lamina, James Fotheringham, Marc Froissart, Kai‐Uwe Eckardt, +4 more
23citations -
Levothyroxine treatment response of cardiometabolic biomarkers in older adults with subclinical hypothyroidism2026 The Journal of Clinical Endocrinology & Metabolism article Medicine Thyroid Disorders and Treatments Open access
Linjun Ao, Raymond Noordam, Stella Trompet, Nicolien A van Vliet, Naveed A. Sattar, Nicolas Rodondi, +10 more
3citations -
Efficacy of a hypolipid diet in patients with primary antiphospholipid syndrome with dyslipidemia: a prospective study2021 Journal of Thrombosis and Thrombolysis article Medicine Systemic Lupus Erythematosus Research Open access
Thays de Cássia Ruiz Rodrigues, Camila de Oliveira Vaz, ELIANA CRISTINA MARTINS MIRANDA, Marcos Emanoel Pereira, Sabrina da Silva Saraiva, Joyce Maria Annichino‐Bizzacchi, +2 more
7citations -
Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP Mice2021 Arteriosclerosis Thrombosis and Vascular Biology article Medicine Cholesterol and Lipid Metabolism Open access
Enchen Zhou, Li Zhuang, Hiroyuki Nakashima, Cong Liu, Zhixiong Ying, Amanda C. Foks, +4 more
11citations